Top 5% on LinkedIn

February 12, 2013

Dr. Gina had one of the top 5% most viewed LinkedIn profiles for 2012! The content on this blog also posts to Linkedin, and it is refreshing to know that the messages we share with you here, about health and medicine, are reaching a large and influential audience.

In health,

Dr. Gina and all of us at HealthBridge Medical Center


Dr. Gina on “Healthy Talk” Radio

December 4, 2012

Dr. Gina CushmanGina Cushman, NMD, PhD, owner of HealthBridge Medical Center in Newport Beach, CA, will be on the radio Wednesday, December 5th from 1 to 2 p.m. ET.

The radio show is “Healthy Talk,” with host Mike Smith, MD, a popular guest on Suzanne Somers’ new television show, “The Suzanne Show.”  The show is sponsored by Life Extension.

Listen to Dr. Gina talk about women’s health and hormone balance  LIVE on wwnnradio.com. The program will also be archived at lef.org/healthytalk.


Concierge Integrative Medical Services

November 4, 2012

Just a quick post to share my excitement as our medical practice expands to offer to our patients the only medical service of its kind in southern California.

As you know, I am passionate about integrative medicine, and after 15 years treating patients and teaching physicians how to practice this medicine, I am still in awe of the results that come with helping the body to heal itself.  There are natural options available for major health challenges, like depression, infertility, ADHD, hormone imbalance, memory loss, chronic pain, and rheumatoid arthritis.

I have been practicing concierge medicine with our high profile patients and am now offering this service to more people.

As a concierge patient you have the option for home visits, a private line to the doctor, help with shopping for the best foods for your body, and a more personal and direct relationship, the way medicine used to be practiced, when your doctor was also a family friend.

Read about our patients’ experiences to learn firsthand from others who have gotten results with the help of this medicine.

You can call our offices at 310-734-0950 (Beverly Hills) or 949-715-9321 (Newport Beach) for more info.

In health,
Dr. Gina

Urgent!!! Protect your Right to a Safe Food Supply and a Healthy Environment. Act TODAY!

June 27, 2012

Below is a news release from Food Democracy Now! that reveals a concerning provision to be considered by the House of Representatives THIS WEEK that takes away the federal court’s ability (and constitutional mandate) to stop the planting and sale of  genetically modified crops (GMO crops) during a legal process of appeals when the safety of these foods, our rights as consumers, and the health of the environment are in question. Please take action today to protect your rights to healthy food before corporate profits.

In health,

-Dr. Gina

Stop the Monsanto Protection Act!

This week the House of Representatives will consider a provision to House Agricultural Appropriations Bill that will fundamentally undermine the concept of judicial review. Hidden under the guise of a “Farmer Assurance Provision” (Section 733), the provision strips the rights of federal courts to halt the sale and planting of genetically engineered crops during the legal appeals process. In the past, legal advocates have successfully won in court the right to halt the sale and planting of unapproved GMO crops while the approval of those crops is under review by a federal judge. This dangerous new House provision, which were calling the Monsanto Protection Act, would strip judges of their constitutional mandate to protect consumer rights and the environment, while opening up a floodgate of planting of new untested genetically engineered crops, endangering farmers, consumers and the environment.

Once again, Monsanto and the biotech industry are working behind closed doors to undermine your basic rights.

This time they’ve gone too far! Join us in putting a stop to the Monsanto Protection Act!


DR. CUSHMAN PUBLISHES PEER REVIEWED RESEARCH ARTICLE ON KEY NUTRACEUTICALS

May 3, 2012

 

FOR IMMEDIATE RELEASE

A new peer reviewed article entitled “Primary Risks of Oral Contraceptives and HRT” discusses the benefits of two nutraceuticals- BRM4 and Plasmanex1, manufactured by Daiwa Pharmaceuticals, and researched by Dr. Gina Cushman in clinical practice.

(Newport Beach, CA) May 3, 2012- Gina Cushman, NMD, PhD, owner and founder of HealthBridge Medical Center and HealthBridge Management LLC in Newport Beach, CA  has just been published in the peer reviewed Natural Medicine Journal, the official journal of the American Association of Naturopathic Physicians. She discusses ways to offset the primary risks that women face when taking hormone replacement therapy (HRT) and oral contraceptives (OC) prescribed by their physicians, including the use of 2 natural food extracts–Plasmanex1 and BRM4–one showing anticoagulant effects and the other exhibiting certain anti-inflammatory and immunomodulatory effects.  Her discussion is based on the results of a clinical research study on the extracts, that was led by Dr. Cushman at her medical practice, and presented worldwide at three PharmCon peer-reviewed continuing medical education events on June 9th, 2011; July 7th, 2011; and August 10th, 2011.   

“I am pleased to see that our team at HealthBridge was able to research these nutraceuticals in a real world medical practice setting, identifying a new and important application for the products, and then share the results of our research with thousands of physicians and pharmacists worldwide, through continuing medical education seminars and now through publication in a reputable peer-reviewed journal, “ says Dr. Cushman.

Long-term use of OCs and HRT have been linked to increased risks of cardiovascular problems, and chronic immune disorders with an inflammatory component, including cancer.  The research study designed and led by Dr. Cushman investigated the clinical effects of the use of BRM4 (also referred to as BioBran, MGN3 or RBAC in some countries) and Plasmanex1 (NKCP) for the purpose of uncovering potential benefits of combined use, as well as areas that may prove fruitful for further research into ways to prevent serious side effects from OCs/HRT. The 6-week private practitioner research study included case study results that demonstrated the significant impact of these 2 extracts—Plasmanex1 and BRM4—on OC users and HRT users, with regard to offsetting thrombotic risk and improving inflammatory symptoms.

Reference: Cushman, G. Primary Risks of Oral Contraceptives and HRT. Nat Med Journal. May 1, 2012. http://naturalmedicinejournal.com/article_content.asp?edition=1&section=2&article=321

# # #
About HealthBridge Management LLC
HealthBridge Management LLC is a nationally recognized consulting firm specializing in medical marketing, sales and distribution for the pharmaceutical and nutraceutical industries.  HealthBridge delivers simple, affordable and doable medical sales, research and marketing solutions to meet the need, worldwide, for quality education, and access to effective pharmaceutical and nutraceutical products. For further information on our firm, partial client list and client comments, please visit www.HealthBridge.tv or call 949.612.9890.


Live CME Webinar Series on Thyroid Health

April 19, 2012

Join PharmCon’s pharmaceutical webinar series on “Innovative Strategies for Optimizing Thyroid Function” on April 23rd at 10:30 AM EST with Dr. Gina Cushman, NMD, PhD, founder of HealthBridge Management LLC and HealthBridge Medical Center in Newport Beach, CA.

Dr. Cushman will be discussing the benefits and appropriate use of the various thyroid medications available to healthcare practitioners, and a new approach to the diagnosis and treatment of thyroid-related imbalance.

AMA and ACPE approved for 1.25 live pharmaceutical continuing medical education credits. Cost is free to members (nominal $50 annual fee for unlimited access to live CMEs) and $30 to non-members.

Register Now


NEWS Release

March 12, 2012

(Newport Beach, CA) – Due to overwhelming demand and positive feedback from the global healthcare profession, Gina Cushman, NMD, PhD has been invited by PharmCon to deliver a fourth presentation on thyroid health on Monday, April 23rd at 10:30 AM EST. PharmCon is the leading provider of live online continuing education to the healthcare profession through its principal operating division – FreeCE, with over 250,000 registered users.  PharmCon offers healthcare professionals the flexibility and convenience of completing an education program from virtually anywhere.

Feedback from physicians and pharmacists attending Dr. Cushman’s January 2012 lecture included,  “Best program I have EVER attended!”; “What a blessing to have well informed practitioners!!! We need help informing the MD population!”; “Excellent presentation”; “Very effective explanation and treatments”; and “Awesome presentation!!! One of the best!!”

The presentation offering 1.25 hours of LIVE pharmaceutical CE credit hours runs from 10:30 AM to 11:45 AM Eastern on http://www.FreeCe.com. Cost to participate is free to PharmCon members or $30 per person.


Thyroid Presentation Post Program Evaluation

November 28, 2011

Dr. Cushman’s lecture today on “Innovative Strategies for Optimizing Thyroid Function” was a great success.  Here are just a few comments from the physicians and pharmacists in attendance:

“Thanks Dr Cushman,excellent presentation.”

“Would love to see more programs with Dr. Gina – so interesting – she is GREAT!”

“Please get Dr. Cushman back often. She’s excellent.”

“The best one on this [Live Continuing Medical Education] website.”

“Excellent speaker!

“Excellent speaker and welcomed content!”

“Excellent presentation!”

“Excellent breakdown and explanation of the key differences between thyroid products.”

Don’t miss her next presentation scheduled for Thursday, December 15th 2011 on www.freece.com and receive 1.25 hours of live continuing education pharmaceutical credits!

 


24 Hours to Take Action: Monsanto Pushes USDA to Approve GMO Drought Corn

August 11, 2011

Below is a call to action by Food Democracy Now! regarding the approval of another Monsanto GMO product.  More research is pointing to the fact that GMO products do impact our health, can affect fertility, and cause pesticide residue to linger in the blood. Until the due diligence is done on the long term health consequences of GMO products, let’s hold off on introducing more GMO products into the environment.

In health,

-Dr. G

Monsanto pushes USDA to approve GMO drought corn – Tell the USDA what you think!

As if genetically engineered alfalfa, corn for ethanol, sugar beets, and most recently Kentucky bluegrass for lawns weren’t enough, the Obama USDA is now poised to approve another unnecessary GMO crop, in lieu of independent scientific data and practice of precautionary principles.

Currently, Monsanto is seeking approval from the USDA of a drought resistant corn known as MON 87460, which Monsanto claims achieves better results under low-water conditions compared to other varieties. Even the USDA’s own assessment shows that MON 87460 is no more “drought-tolerant” than current corn varieties nor does it have the true long-term potential benefits to meet drought conditions that farming with organic corn can bring to farmers.

Unfortunately, like all GMO approval processes in the U.S., the USDA has relied heavily on Monsanto’s own corporate science and failed to get adequate independent, peer reviewed data regarding the safety of this new GMO drought corn or of Monsanto’s claims.

It would appear that the “science” used to rationalize the approval for yet another GMO crop is biased to the benefit of Monsanto, ignoring the needs of farmers, the environment and the health of the population. The USDA public comment for approval of MON ends tomorrow

Let your voice be heard – Tell the USDA today to reject Monsanto’s GMO drought-resistant corn.

http://action.fooddemocracynow.org/go/399?akid=362.169161.6a0G4f&t=9

British Scientists Find GMO Horizontal Gene Transfer

In what can only be a glaring scientific oversight, the USDA assessment readily admits that “horizontal gene transfer” of DNA is a common event in nature, but somehow diminishes the potential for the novel genetic components found in Monsanto’s GMO drought corn to be capable of such leaps. Current ag biotechnology relies on a crude insertion of GMO genes done in scattershot fashion, which are by their very creation designed to cross previously untraversable genetic barriers imposed by nature.

More alarming is the fact that scientists in England have found that “horizontal gene transfer” of one of the main GMO genetic components found in MON 87460 has already occurred. Just last year scientists at University of Bristol “identified a natural process they say that would allow synthetic genes to move across GM organisms and out into the wild.”

According to the USDA’s own assessment, Monsanto’s GMO drought corn “was developed through a plant pathogenic bacterium Agrobacterium tumefaciens mediated transformation”. It is the same Agrobacterium tumefaciens that British researchers found that “‘transforms’ plant tissue at ‘plant wound’ sites and ‘clearly demonstrates that when placed together on damaged plant tissue, Agrobacterium readily transforms associated fungi’”.

It is hard to understand how scientists at the main U.S. government oversight agency could miss these facts in their own assessment of a new GMO crop, but like previous administrations, officials in the Obama administration appear more interested in fast-tracking Monsanto’s GMO technology.

Tell the USDA that they need to reject Monsanto’s studies of their own products and demand more independent peer reviewed data before it can approve any more GMO crops.

Monsanto’s Missing GMO Genes: Where did they GO?

On top of this, the current USDA assessment for Monsanto’s GMO drought corn readily admits that multiple GMO genetic components “did not get incorporated into the transformed plant”. Even as Monsanto attempts to diminish this alarming finding, the USDA also admits “a 22 base pair length of genomic DNA got deleted at the insert-to-plant DNA junction in MON 87460.”

Despite these disturbing scientific anomalies, which the USDA calls “minor genetic sequence modifications” the agency concludes there is no “biologically meaningful difference between MON 87460 and conventional corn.”

Do you believe them?

Bt toxin from GMO Corn Found in Pregnant Mothers

This past spring, further punctuating the point of gene trasference from plants to humans, Canadian scientists alarmingly discovered traces of the Bt toxin from GMO corn – engineered to release an insecticide – in 93% of blood samples taken from pregnant women and 80% umbilical cords tested.

This discovery comes in spite of promises by ag biotech companies such as Monsanto that this was not possible.

For any mother or parent such findings should bring about a sobering awakening that U.S. governmental regulatory agencies are not adequately doing their jobs and that more independent peer reviewed studies must be conducted before any more GMO crops are approved by the USDA or the Obama administration.

Click here to send in your public comment to tell the USDA that they need to reject Monsanto’s studies of their own products and demand more independent peer reviewed data before they can approve any more GMO crops.

http://action.fooddemocracynow.org/go/399?akid=362.169161.6a0G4f&t=12

Thanks for participating in food democracy,

Dave, Lisa and the Food Democracy Now! Team

Sources:

1. “PLANT PEST RISK ASSESSMENT FOR MON 87460 CORN” U.S. Department of Agriculture, Animal and Plant Health Inspection Service.

http://action.fooddemocracynow.org/go/403?akid=362.169161.6a0G4f&t=14

2. “Scientists Discover New Route for GM Contamination”, November 4, 2010 Farmers Guardian. http://action.fooddemocracynow.org/go/401?akid=362.169161.6a0G4f&t=16

3. “GM food toxins found in the blood of 93% of unborn babies”, May 20, 2011, UK Daily Mail.

http://action.fooddemocracynow.org/go/402?akid=362.169161.6a0G4f&t=18


Cocoa Flavonols: Vision And Cognitive Function – Nutraceuticals World

August 3, 2011

Cocoa Flavonols: Vision And Cognitive Function

Good news for those of us who love dark chocolate!

Dr. G